{"id": "-57kTacAAAAJ", "citedby": 17800, "citedby5y": 10157, "hindex": 61, "hindex5y": 47, "i10index": 118, "i10index5y": 88, "coauthors": [{"id": "QcVTkn0AAAAJ", "name": "Hilary A. Kenny", "affiliation": "Gordon Center of Integrative Sciences, University of Chicago"}, {"id": "uFrilFcAAAAJ", "name": "Iris Romero", "affiliation": "University of Chciago"}, {"id": "e9p7q6MAAAAJ", "name": "Marcus E. Peter", "affiliation": "Northwestern University"}, {"id": "DFAVbYwAAAAJ", "name": "Christine Feig", "affiliation": ""}, {"id": "pTAd4aQAAAAJ", "name": "Emily Kistner-Griffin", "affiliation": "Medical University of South Carolina"}, {"id": "QH9nf48AAAAJ", "name": "Maria Tretiakova", "affiliation": "Anatomic and Clinical pathologist, Associate Professor, University of Washington"}], "name": "Ernst Lengyel", "affiliation": "Professor of Gynecologic Oncology, University of Chicago", "interests": ["ovarian cancer"], "cites_per_year": {"1998": 50, "1999": 107, "2000": 102, "2001": 147, "2002": 178, "2003": 212, "2004": 200, "2005": 235, "2006": 197, "2007": 242, "2008": 321, "2009": 481, "2010": 636, "2011": 809, "2012": 925, "2013": 1164, "2014": 1433, "2015": 1485, "2016": 1833, "2017": 1899, "2018": 1885, "2019": 2062, "2020": 980}, "publications": [{"bib": {"title": "The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2", "year": "2008"}, "source": "citations", "id_citations": "-57kTacAAAAJ:u5HHmVD_uO8C", "citedby": "2179"}, {"bib": {"title": "Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:maZDTaKrznsC", "citedby": "1196"}, {"bib": {"title": "Ovarian cancer development and metastasis", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4TOpqqG69KYC", "citedby": "999"}, {"bib": {"title": "Rethinking ovarian cancer: recommendations for improving outcomes", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:iH-uZ7U-co4C", "citedby": "975"}, {"bib": {"title": "Whole\u2013genome characterization of chemoresistant ovarian cancer", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:z_wVstp3MssC", "citedby": "757"}, {"bib": {"title": "Let-7 expression defines two differentiation stages of cancer", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:9yKSN-GCB0IC", "citedby": "495"}, {"bib": {"title": "Adipose tissue and adipocytes support tumorigenesis and metastasis", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:u9iWguZQMMsC", "citedby": "456"}, {"bib": {"title": "Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:BUYA1_V_uYcC", "citedby": "449"}, {"bib": {"title": "Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:qjMakFHDy7sC", "citedby": "447"}, {"bib": {"title": "Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b", "year": "2000"}, "source": "citations", "id_citations": "-57kTacAAAAJ:2osOgNQ5qMEC", "citedby": "437"}, {"bib": {"title": "Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites \u2026", "year": "1996"}, "source": "citations", "id_citations": "-57kTacAAAAJ:u-x6o8ySG0sC", "citedby": "388"}, {"bib": {"title": "CD95 promotes tumour growth", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Se3iqnhoufwC", "citedby": "361"}, {"bib": {"title": "The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin", "year": "2008"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Y0pCki6q_DkC", "citedby": "329"}, {"bib": {"title": "Loss of E-cadherin promotes ovarian cancer metastasis via \u03b15-integrin, which is a therapeutic target", "year": "2008"}, "source": "citations", "id_citations": "-57kTacAAAAJ:YsMSGLbcyi4C", "citedby": "327"}, {"bib": {"title": "Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:IjCSPb-OGe4C", "citedby": "275"}, {"bib": {"title": "C\u2010Met overexpression in node\u2010positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu", "year": "2005"}, "source": "citations", "id_citations": "-57kTacAAAAJ:zYLM7Y9cAGgC", "citedby": "273"}, {"bib": {"title": "Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy", "year": "2006"}, "source": "citations", "id_citations": "-57kTacAAAAJ:5nxA0vEk-isC", "citedby": "267"}, {"bib": {"title": "Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase-and the extracellular signal-regulated kinase-dependent signaling cascades", "year": "1997"}, "source": "citations", "id_citations": "-57kTacAAAAJ:d1gkVwhDpl0C", "citedby": "266"}, {"bib": {"title": "c-Met overexpression is a prognostic factor in ovarian cancer and an effective target for inhibition of peritoneal dissemination and invasion", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Tyk-4Ss8FVUC", "citedby": "264"}, {"bib": {"title": "MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:OU6Ihb5iCvQC", "citedby": "240"}, {"bib": {"title": "Use of a novel 3D culture model to elucidate the role of mesothelial cells, fibroblasts and extra\u2010cellular matrices on adhesion and invasion of ovarian cancer cells to the omentum", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:kNdYIx-mwKoC", "citedby": "211"}, {"bib": {"title": "Ligand-independent activation of c-Met by fibronectin and \u03b1 5 \u03b2 1-integrin regulates ovarian cancer invasion and metastasis", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:L8Ckcad2t8MC", "citedby": "196"}, {"bib": {"title": "Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation", "year": "2004"}, "source": "citations", "id_citations": "-57kTacAAAAJ:_FxGoFyzp5QC", "citedby": "186"}, {"bib": {"title": "Epithelial ovarian cancer experimental models", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:wbdj-CoPYUoC", "citedby": "158"}, {"bib": {"title": "Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:PR6Y55bgFSsC", "citedby": "155"}, {"bib": {"title": "Relationship of type II diabetes and metformin use to ovarian cancer progression, survival, and chemosensitivity", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:cFHS6HbyZ2cC", "citedby": "145"}, {"bib": {"title": "MMP-2 functions as an early response protein in ovarian cancer metastasis", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:9ZlFYXVOiuMC", "citedby": "145"}, {"bib": {"title": "The urokinase plasminogen activator system as a novel target for tumour therapy", "year": "2000"}, "source": "citations", "id_citations": "-57kTacAAAAJ:UeHWp8X0CEIC", "citedby": "140"}, {"bib": {"title": "Let\u20107 modulates acquired resistance of ovarian cancer to Taxanes via IMP\u20101\u2010mediated stabilization of multidrug resistance 1", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:hFOr9nPyWt4C", "citedby": "138"}, {"bib": {"title": "MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:uJ-U7cs_P_0C", "citedby": "132"}, {"bib": {"title": "Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:eQOLeE2rZwMC", "citedby": "128"}, {"bib": {"title": "A phase II, single-arm study of the anti-\u03b15\u03b21 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal \u2026", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:R3hNpaxXUhUC", "citedby": "122"}, {"bib": {"title": "m 6 A mRNA methylation regulates AKT activity to promote the proliferation and tumorigenicity of endometrial cancer", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4vMrXwiscB8C", "citedby": "120"}, {"bib": {"title": "MicroRNAs in ovarian carcinomas", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:OcBU2YAGkTUC", "citedby": "119"}, {"bib": {"title": "Elevated keratin 18 protein expression indicates a favorable prognosis in patients with breast cancer.", "year": "1996"}, "source": "citations", "id_citations": "-57kTacAAAAJ:WF5omc3nYNoC", "citedby": "114"}, {"bib": {"title": "Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:M3NEmzRMIkIC", "citedby": "108"}, {"bib": {"title": "Metformin targets central carbon metabolism and reveals mitochondrial requirements in human cancers", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:i2xiXl-TujoC", "citedby": "105"}, {"bib": {"title": "HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:KxtntwgDAa4C", "citedby": "105"}, {"bib": {"title": "Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:tzM49s52ZIMC", "citedby": "103"}, {"bib": {"title": "Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:M7yex6snE4oC", "citedby": "101"}, {"bib": {"title": "Requirement of an upstream AP-1 motif for the constitutive and phorbol ester-inducible expression of the urokinase-type plasminogen activator receptor gene", "year": "1996"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ufrVoPGSRksC", "citedby": "101"}, {"bib": {"title": "Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor", "year": "1999"}, "source": "citations", "id_citations": "-57kTacAAAAJ:W7OEmFMy1HYC", "citedby": "100"}, {"bib": {"title": "Induction of Mr 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts", "year": "1995"}, "source": "citations", "id_citations": "-57kTacAAAAJ:roLk4NBRz8UC", "citedby": "96"}, {"bib": {"title": "Genomics of ovarian cancer progression reveals diverse metastatic trajectories including intraepithelial metastasis to the fallopian tube", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:S16KYo8Pm5AC", "citedby": "91"}, {"bib": {"title": "Integrin \u03b1v\u03b23/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:hqOjcs7Dif8C", "citedby": "91"}, {"bib": {"title": "Thrombin induces tumor invasion through the induction and association of matrix metalloproteinase-9 and \u03b21-integrin on the cell surface", "year": "2008"}, "source": "citations", "id_citations": "-57kTacAAAAJ:YOwf2qJgpHMC", "citedby": "90"}, {"bib": {"title": "miR-92a inhibits peritoneal dissemination of ovarian cancer cells by inhibiting integrin \u03b15 expression", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:XiSMed-E-HIC", "citedby": "87"}, {"bib": {"title": "Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:hkOj_22Ku90C", "citedby": "84"}, {"bib": {"title": "Exosomes promote ovarian cancer cell invasion through transfer of CD44 to peritoneal mesothelial cells", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:e_rmSamDkqQC", "citedby": "82"}, {"bib": {"title": "Involvement of a mitogen-activated protein kinase signaling pathway in the regulation of urokinase promoter activity by c-Ha-ras", "year": "1995"}, "source": "citations", "id_citations": "-57kTacAAAAJ:LkGwnXOMwfcC", "citedby": "81"}, {"bib": {"title": "Adipocyte-induced CD36 expression drives ovarian cancer progression and metastasis", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:a9-T7VOCCH8C", "citedby": "79"}, {"bib": {"title": "\u03b23-integrin expression on tumor cells inhibits tumor progression, reduces metastasis, and is associated with a favorable prognosis in patients with ovarian cancer", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:7PzlFSSx8tAC", "citedby": "75"}, {"bib": {"title": "Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1 \u2026", "year": "1997"}, "source": "citations", "id_citations": "-57kTacAAAAJ:8k81kl-MbHgC", "citedby": "74"}, {"bib": {"title": "An orally available small-molecule inhibitor of c-Met, PF-2341066, reduces tumor burden and metastasis in a preclinical model of ovarian cancer metastasis", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Wp0gIr-vW9MC", "citedby": "72"}, {"bib": {"title": "Cancer as a matter of fat: the crosstalk between adipose tissue and tumors", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4hFrxpcac9AC", "citedby": "71"}, {"bib": {"title": "In vitro modulation of human melanoma cell invasion and proliferation by all-trans-retinoic acid.", "year": "1998"}, "source": "citations", "id_citations": "-57kTacAAAAJ:UebtZRa9Y70C", "citedby": "71"}, {"bib": {"title": "Tyrosine kinase mutations in human cancer", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:KlAtU1dfN6UC", "citedby": "69"}, {"bib": {"title": "Targeting the urokinase plasminogen activator receptor inhibits ovarian cancer metastasis", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:TQgYirikUcIC", "citedby": "68"}, {"bib": {"title": "WNT7A/\u03b2-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:1yQoGdGgb4wC", "citedby": "63"}, {"bib": {"title": "Microenvironment-induced downregulation of miR-193b drives ovarian cancer metastasis", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:evX43VCCuoAC", "citedby": "62"}, {"bib": {"title": "\u03b23A-Integrin Downregulates the Urokinase-Type Plasminogen Activator Receptor (u-PAR) through aPEA3/ets Transcriptional Silencing Element in the u-PAR Promoter", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:0EnyYjriUFMC", "citedby": "62"}, {"bib": {"title": "Molecular pathways: trafficking of metabolic resources in the tumor microenvironment", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:2KloaMYe4IUC", "citedby": "59"}, {"bib": {"title": "Regulation of urokinase\u2010type plasminogen activator expression by an ERK1\u2010dependent signaling pathway in a squamous cell carcinoma cell line", "year": "1996"}, "source": "citations", "id_citations": "-57kTacAAAAJ:MXK_kJrjxJIC", "citedby": "59"}, {"bib": {"title": "The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:mB3voiENLucC", "citedby": "56"}, {"bib": {"title": "The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:-_dYPAW6P2MC", "citedby": "55"}, {"bib": {"title": "Old drug, new trick: repurposing metformin for gynecologic cancers?", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:dQ2og3OwTAUC", "citedby": "55"}, {"bib": {"title": "Transient interaction of activated platelets with endothelial cells induces expression of monocyte-chemoattractant protein-1 via a p38 mitogen-activated protein kinase mediated \u2026", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:3fE2CSJIrl8C", "citedby": "55"}, {"bib": {"title": "Expression of the homeobox gene HOXA9 in ovarian cancer induces peritoneal macrophages to acquire an M2 tumor-promoting phenotype", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:olpn-zPbct0C", "citedby": "53"}, {"bib": {"title": "Up-Regulation of \u03b15-Integrin by E-Cadherin Loss in Hypoxia and Its Key Role in the Migration of Extravillous Trophoblast Cells during Early Implantation", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:IWHjjKOFINEC", "citedby": "53"}, {"bib": {"title": "Differential expression of c\u2010Met, its ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:dhFuZR0502QC", "citedby": "52"}, {"bib": {"title": "PDGFR-\u03b1 as a potential therapeutic target in uterine sarcomas", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ZeXyd9-uunAC", "citedby": "50"}, {"bib": {"title": "A novel multipurpose monoclonal antibody for evaluating human c-Met expression in preclinical and clinical settings", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:-f6ydRqryjwC", "citedby": "49"}, {"bib": {"title": "Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Ak0FvsSvgGUC", "citedby": "47"}, {"bib": {"title": "FOXO1 orchestrates the bone-suppressing function of gut-derived serotonin", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:dshw04ExmUIC", "citedby": "47"}, {"bib": {"title": "The first line of intra-abdominal metastatic attack: breaching the mesothelial cell layer", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:D03iK_w7-QYC", "citedby": "46"}, {"bib": {"title": "Fibroblasts mobilize tumor cell glycogen to promote proliferation and metastasis", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:mNrWkgRL2YcC", "citedby": "45"}, {"bib": {"title": "Reversal of chemoresistance in ovarian cancer by co-delivery of a P-glycoprotein inhibitor and paclitaxel in a liposomal platform", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:VaXvl8Fpj5cC", "citedby": "44"}, {"bib": {"title": "Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:yMeIxYmEMEAC", "citedby": "42"}, {"bib": {"title": "Three-dimensional modeling of ovarian cancer", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:_B80troHkn4C", "citedby": "42"}, {"bib": {"title": "Does equal treatment yield equal outcomes? The impact of race on survival in epithelial ovarian cancer", "year": "2008"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4JMBOYKVnBMC", "citedby": "42"}, {"bib": {"title": "UVB increases urokinase-type plasminogen activator receptor (uPAR) expression", "year": "1999"}, "source": "citations", "id_citations": "-57kTacAAAAJ:_kc_bZDykSQC", "citedby": "39"}, {"bib": {"title": "Statin therapy is associated with improved survival in patients with non-serous-papillary epithelial ovarian cancer: a retrospective cohort analysis", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ye4kPcJQO24C", "citedby": "38"}, {"bib": {"title": "Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/pc-Jun in colorectal cancer", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:qxL8FJ1GzNcC", "citedby": "37"}, {"bib": {"title": "Gastrin induces expression and promoter activity of the vesicular monoamine transporter subtype 2", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Zph67rFs4hoC", "citedby": "37"}, {"bib": {"title": "Stimulation of urokinase expression by TNF-\u03b1 requires the activation of binding sites for the AP-1 and PEA3 transcription factors", "year": "1995"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ULOm3_A8WrAC", "citedby": "35"}, {"bib": {"title": "Who are the long-term survivors of high grade serous ovarian cancer?", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:GtLg2Ama23sC", "citedby": "34"}, {"bib": {"title": "Autophagy and thyroid carcinogenesis: genetic and epigenetic links", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:cWzG1nlazyYC", "citedby": "33"}, {"bib": {"title": "Downregulation of a mitogen-activated protein kinase signaling pathway in the placentas of women with preeclampsia", "year": "2000"}, "source": "citations", "id_citations": "-57kTacAAAAJ:hC7cP41nSMkC", "citedby": "33"}, {"bib": {"title": "Tumor-specific transcription factor binding to an activator protein-2/Sp1 element of the urokinase-type plasminogen activator receptor promoter in a first large series of \u2026", "year": "2003"}, "source": "citations", "id_citations": "-57kTacAAAAJ:aqlVkmm33-oC", "citedby": "31"}, {"bib": {"title": "Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:nrtMV_XWKgEC", "citedby": "30"}, {"bib": {"title": "Combination analysis of activator protein-1 family members, Sp1 and an activator protein-2\u03b1-related factor binding to different regions of the urokinase receptor gene in \u2026", "year": "2005"}, "source": "citations", "id_citations": "-57kTacAAAAJ:mVmsd5A6BfQC", "citedby": "29"}, {"bib": {"title": "Regulation of urokinase-type plasminogen activator expression by the v-mos oncogene.", "year": "1995"}, "source": "citations", "id_citations": "-57kTacAAAAJ:UxriW0iASnsC", "citedby": "29"}, {"bib": {"title": "Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:OR75R8vi5nAC", "citedby": "28"}, {"bib": {"title": "Up-regulation of urokinase-type plasminogen activator expression by the HER2/neu proto-oncogene.", "year": "1995"}, "source": "citations", "id_citations": "-57kTacAAAAJ:M3ejUd6NZC8C", "citedby": "28"}, {"bib": {"title": "Hyperglycemia-induced metabolic compensation inhibits metformin sensitivity in ovarian cancer", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:yB1At4FlUx8C", "citedby": "27"}, {"bib": {"title": "Patterns and utility of routine surveillance in high grade endometrial cancer", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:fEOibwPWpKIC", "citedby": "26"}, {"bib": {"title": "Rac1 and Rho contribute to the migratory and invasive phenotype associated with somatic E-cadherin mutation", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:r0BpntZqJG4C", "citedby": "26"}, {"bib": {"title": "A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:tYavs44e6CUC", "citedby": "25"}, {"bib": {"title": "Urokinase Plasminogen Activator System\u2013Targeted Delivery of Nanobins as a Novel Ovarian Cancer Therapy", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:5ugPr518TE4C", "citedby": "24"}, {"bib": {"title": "Induction of Neoantigen-Specific Cytotoxic T Cells and Construction of T-cell Receptor\u2013Engineered T Cells for Ovarian Cancer", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:sNmaIFBj_lkC", "citedby": "23"}, {"bib": {"title": "Role of \u03b23-endonexin in the regulation of NF-\u03baB-dependent expression of urokinase-type plasminogen activator receptor", "year": "2002"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4DMP91E08xMC", "citedby": "23"}, {"bib": {"title": "Cytological diagnosis of zosteriform skin metastases in undiagnosed breast carcinoma", "year": "1996"}, "source": "citations", "id_citations": "-57kTacAAAAJ:QIV2ME_5wuYC", "citedby": "23"}, {"bib": {"title": "Clinico-pathologic comparison of type II endometrial cancers based on tamoxifen exposure", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:P5F9QuxV20EC", "citedby": "21"}, {"bib": {"title": "The expression of hepatocyte growth factor (HGF) and c-Met in uterine serous carcinoma", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:NMxIlDl6LWMC", "citedby": "21"}, {"bib": {"title": "The M\u00fcllerian HOXA10 gene promotes growth of ovarian surface epithelial cells by stimulating epithelial\u2013stromal interactions", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:JV2RwH3_ST0C", "citedby": "20"}, {"bib": {"title": "The plasminogen activation system as a novel target for therapeutic strategies", "year": "2000"}, "source": "citations", "id_citations": "-57kTacAAAAJ:b0M2c_1WBrUC", "citedby": "20"}, {"bib": {"title": "Platelets, coagulation, and the liver", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:RHpTSmoSYBkC", "citedby": "19"}, {"bib": {"title": "Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:j3f4tGmQtD8C", "citedby": "19"}, {"bib": {"title": "Phase II study of comparing volociximab (an antiangiogenic antibody) and peglylated liposomal doxorubicin (PLD) with PLD alone in recurrent ovarian or primary peritoneal cancer", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:abG-DnoFyZgC", "citedby": "19"}, {"bib": {"title": "Reversible posterior leukoencephalopathy syndrome following intravenous paclitaxel and intraperitoneal cisplatin chemotherapy for fallopian tube cancer", "year": "2008"}, "source": "citations", "id_citations": "-57kTacAAAAJ:bEWYMUwI8FkC", "citedby": "18"}, {"bib": {"title": "Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:p2g8aNsByqUC", "citedby": "17"}, {"bib": {"title": "An activity-dependent proximity ligation platform for spatially resolved quantification of active enzymes in single cells", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:FAceZFleit8C", "citedby": "15"}, {"bib": {"title": "Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia", "year": "2004"}, "source": "citations", "id_citations": "-57kTacAAAAJ:_Qo2XoVZTnwC", "citedby": "15"}, {"bib": {"title": "FOXL2 and SOX9 Distinguish the Lineage of the Sex Cord\u2013Stromal Cells in Gonadoblastomas", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ldfaerwXgEUC", "citedby": "14"}, {"bib": {"title": "A high-throughput screening model of the tumor microenvironment for ovarian cancer cell growth", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ruyezt5ZtCIC", "citedby": "13"}, {"bib": {"title": "Die Physiologie der Zervixreifung", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:e5wmG9Sq2KIC", "citedby": "13"}, {"bib": {"title": "High glucocorticoid receptor expression predicts short progression-free survival in ovarian cancer", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:hCrLmN-GePgC", "citedby": "11"}, {"bib": {"title": "The effects of 17\u03b2-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:yD5IFk8b50cC", "citedby": "10"}, {"bib": {"title": "A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:3htObqc8RwsC", "citedby": "9"}, {"bib": {"title": "Unsaturated fatty acids maintain cancer cell stemness", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Ug5p-4gJ2f0C", "citedby": "9"}, {"bib": {"title": "Ras regulation of urokinase-type plasminogen activator", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:HDshCWvjkbEC", "citedby": "9"}, {"bib": {"title": "Modeling the early steps of ovarian cancer dissemination in an organotypic culture of the human peritoneal cavity", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4MWp96NkSFoC", "citedby": "8"}, {"bib": {"title": "JNK and p38MAPK are activated during graft reperfusion and not during cold storage in rat liver transplantation", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:qUcmZB5y_30C", "citedby": "8"}, {"bib": {"title": "Keratin expression reveals mosaic differentiation in vaginal epithelium", "year": "1993"}, "source": "citations", "id_citations": "-57kTacAAAAJ:isC4tDSrTZIC", "citedby": "8"}, {"bib": {"title": "Critical questions in ovarian cancer research and treatment: Report of an American Association for Cancer Research Special Conference", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:nVrZBo8bIpAC", "citedby": "7"}, {"bib": {"title": "Loss of BRCA1 in the cells of origin of ovarian cancer induces glycolysis: a window of opportunity for ovarian cancer chemoprevention", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:edDO8Oi4QzsC", "citedby": "7"}, {"bib": {"title": "The road to long-term survival: Surgical approach and longitudinal treatments of long-term survivors of advanced-stage serous ovarian cancer", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:KbBQZpvPDL4C", "citedby": "6"}, {"bib": {"title": "The tumor microenvironment takes center stage in ovarian cancer metastasis", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:6ZxmRoH8BuwC", "citedby": "6"}, {"bib": {"title": "Prolactin Receptor\u2013Mediated Internalization of Imaging Agents Detects Epithelial Ovarian Cancer with Enhanced Sensitivity and Specificity", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:XoXfffV-tXoC", "citedby": "5"}, {"bib": {"title": "Acute inflammatory reaction following placement of sodium hyaluronate-carboxymethylcellulose barrier in a young woman undergoing gynecologic surgery: a case report.", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:RGFaLdJalmkC", "citedby": "5"}, {"bib": {"title": "First evidence for the new tumor suppressor Pdcd4 as a regulator of u-PAR, an invasion-related gene", "year": "2003"}, "source": "citations", "id_citations": "-57kTacAAAAJ:k_IJM867U9cC", "citedby": "5"}, {"bib": {"title": "The clinical importance of keratin 18 in breast cancer", "year": "1999"}, "source": "citations", "id_citations": "-57kTacAAAAJ:TFP_iSt0sucC", "citedby": "5"}, {"bib": {"title": "A streamlined mass spectrometry\u2013based proteomics workflow for large\u2010scale FFPE tissue analysis", "year": "2020"}, "source": "citations", "id_citations": "-57kTacAAAAJ:jgBuDB5drN8C", "citedby": "4"}, {"bib": {"title": "SPHK1 is a novel target of metformin in ovarian cancer", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:HeT0ZceujKMC", "citedby": "4"}, {"bib": {"title": "Isolation and characterization of Rac1 pseudogenes (\u03c81Rac1\u2013\u03c84Rac1) in the human genome", "year": "2004"}, "source": "citations", "id_citations": "-57kTacAAAAJ:blknAaTinKkC", "citedby": "4"}, {"bib": {"title": "Inhibition of fascin in cancer and stromal cells blocks ovarian cancer metastasis", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:5MTHONV0fEkC", "citedby": "3"}, {"bib": {"title": "Mutant p53 regulates LPA signaling through lysophosphatidic acid phosphatase type 6", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:gKiMpY-AVTkC", "citedby": "3"}, {"bib": {"title": "Ultrasensitive, multiplexed chemoproteomic profiling with soluble activity-dependent proximity ligation", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:U4n9YNQMCAIC", "citedby": "2"}, {"bib": {"title": "Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:kVjdVfd2voEC", "citedby": "2"}, {"bib": {"title": "The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:r_AWSJRzSzQC", "citedby": "2"}, {"bib": {"title": "The c-Met/VEGFR2 inhibitor, XL880, inhibits ovarian cancer cell growth", "year": "2008"}, "source": "citations", "id_citations": "-57kTacAAAAJ:1qzjygNMrQYC", "citedby": "2"}, {"bib": {"title": "Treatment with an uPAR (ATN 658) antibody inhibits ovarian cancer metastasis.", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:tOudhMTPpwUC", "citedby": "2"}, {"bib": {"title": "Src-induced uPAR gene expression is also mediated via an AP-1 motif and is associated with increased invasive capacity in vivo", "year": "2005"}, "source": "citations", "id_citations": "-57kTacAAAAJ:hMod-77fHWUC", "citedby": "2"}, {"bib": {"title": "Mesothelial Cell HIF1\u03b1 Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:7wO8s98CvbsC", "citedby": "1"}, {"bib": {"title": "RADAR: Differential analysis of MeRIP-seq data with a random effect model", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:IaI1MmNe2tcC", "citedby": "1"}, {"bib": {"title": "New Roles for Glycogen in Tumor Progression", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4X0JR2_MtJMC", "citedby": "1"}, {"bib": {"title": "Interpretation of Mismatch Repair Protein Immunohistochemistry in Endometrial Carcinoma Should Consider Both Lynch Syndrome Screening and Immunotherapy Susceptibility: An \u2026", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:lvd772isFD0C", "citedby": "1"}, {"bib": {"title": "Nicotinamide N-methyltransferase metabolically reprograms the stroma to promote ovarian cancer metastasis.", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:HtS1dXgVpQUC", "citedby": "1"}, {"bib": {"title": "Metformin inhibits TGF\u03b2-induced stromal ECM remodeling to impede invasion in ovarian cancer", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Ri6SYOTghG4C", "citedby": "1"}, {"bib": {"title": "Erratum: Quantitative high throughput screening using a primary human three-dimensional organotypic culture predicts in vivo efficacy", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:EYYDruWGBe4C", "citedby": "1"}, {"bib": {"title": "Receptor-mediated delivery: compositions and methods", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:xtRiw3GOFMkC", "citedby": "1"}, {"bib": {"title": "Abstract POSTER-THER-1409: Targeting p53-FoxM1 axis in ovarian cancer", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:URolC5Kub84C", "citedby": "1"}, {"bib": {"title": "Advancing metformin as a metabolic therapeutic for ovarian cancer: testing in non-diabetic patient-derived xenograft avatars", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:VLnqNzywnoUC", "citedby": "1"}, {"bib": {"title": "Hyperglycemia inhibits the anti-cancer effects of metformin", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ZuybSZzF8UAC", "citedby": "1"}, {"bib": {"title": "Summary of the 2013 American Association for Cancer Research (AACR) Annual Meeting", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:mvPsJ3kp5DgC", "citedby": "1"}, {"bib": {"title": "microRNA mediated reprograming of fibroblasts into cancer associated fibroblasts in ovarian cancer", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Fu2w8maKXqMC", "citedby": "1"}, {"bib": {"title": "FOXL2-a novel marker for granulosa cell tumors", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:738O_yMBCRsC", "citedby": "1"}, {"bib": {"title": "Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:2P1L_qKh6hAC", "citedby": "1"}, {"bib": {"title": "Ovarian cancer treatment in black and white women: A comparison of clinico-pathologic factors and outcome", "year": "2008"}, "source": "citations", "id_citations": "-57kTacAAAAJ:vV6vV6tmYwMC", "citedby": "1"}, {"bib": {"title": "Physiology of cervical ripening and dilatation", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:J_g5lzvAfSwC", "citedby": "1"}, {"bib": {"title": "Promoter analysis of the vesicular monoamine transporter subtype 2 (VMAT2) in PC12 and ECL-cells.", "year": "1999"}, "source": "citations", "id_citations": "-57kTacAAAAJ:YFjsv_pBGBYC", "citedby": "1"}, {"bib": {"title": "Zur klinischen Bedeutung von Keratin 18 beim Mammakarzinom", "year": "1999"}, "source": "citations", "id_citations": "-57kTacAAAAJ:BqipwSGYUEgC", "citedby": "1"}, {"bib": {"title": "Adipocyte-induced FABP4 expression in ovarian cancer cells promotes metastasis and mediates carboplatin resistance", "year": "2020"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Br1UauaknNIC", "citedby": "0"}, {"bib": {"title": "Integrated 5hmC Immunohistochemistry and 5hmC-Modified Genomic Regions as Prognostic Biomarkers in Ovarian Clear Cell Carcinoma", "year": "2020"}, "source": "citations", "id_citations": "-57kTacAAAAJ:6bLC7aUMtPcC", "citedby": "0"}, {"bib": {"title": "Quantitative High-Throughput Screening Using an Organotypic Model Identifies Compounds that Inhibit Ovarian Cancer Metastasis", "year": "2020"}, "source": "citations", "id_citations": "-57kTacAAAAJ:43bX7VzcjpAC", "citedby": "0"}, {"bib": {"title": "Abstract NT-097: QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:nRpfm8aw39MC", "citedby": "0"}, {"bib": {"title": "QUANTITATIVE HIGH-THROUGHPUT SCREENING USING AN ORGANOTYPIC MODEL IDENTIFIES TWO KINASE INHIBITORS THAT INHIBIT OVARIAN CANCER METASTASIS", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:kw52XkFRtyQC", "citedby": "0"}, {"bib": {"title": "Design and Implementation of a 3D Organotypic Model of the Human Mesothelium for High-Throughput Screening.", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:BzfGm06jWhQC", "citedby": "0"}, {"bib": {"title": "Early postoperative increases in platelet count is associated with trend towards improved survival in high grade serous ovarian cancer", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:PVgj2kMGcgYC", "citedby": "0"}, {"bib": {"title": "Profiling the metabolomic composition of the ovarian cancer secretome and ovarian cancer-induced metabolomic changes in mesothelial cells", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:jL-93Qbq4QoC", "citedby": "0"}, {"bib": {"title": "Methods of treating cancers with ct45 targeted therapies", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:2tRrZ1ZAMYUC", "citedby": "0"}, {"bib": {"title": "Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:tH6gc1N1XXoC", "citedby": "0"}, {"bib": {"title": "5-Hydroxymethylcytosine (5-hmC) Is a Novel Prognostic Marker in Ovarian Clear Cell Carcinoma", "year": "2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:lgwcVrK6X84C", "citedby": "0"}, {"bib": {"title": "Stromal regulation of metastasis.", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:bKqednn6t2AC", "citedby": "0"}, {"bib": {"title": "Abstract IA06: Stromal regulation of metastasis", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:HIFyuExEbWQC", "citedby": "0"}, {"bib": {"title": "Abstract A15: Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:dBIO0h50nwkC", "citedby": "0"}, {"bib": {"title": "Abstract A28: Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:QYdC8u9Cj1oC", "citedby": "0"}, {"bib": {"title": "Activity of the S1P pathway promotes ovarian cancer and serves as a novel metabolic target of metformin", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:9c2xU6iGI7YC", "citedby": "0"}, {"bib": {"title": "Polycomb fusion proteins in endometrial stromal sarcomas", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:IUKN3-7HHlwC", "citedby": "0"}, {"bib": {"title": "Diverse indications for risk-reducing salpingo-oophorectomy: Experience from a tertiary care center", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:mlAyqtXpCwEC", "citedby": "0"}, {"bib": {"title": "Heterogeneity of operative approach in long-term survivors of high-grade serous carcinoma", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:WJVC3Jt7v1AC", "citedby": "0"}, {"bib": {"title": "Effective screening of neoantigen-specific cytotoxic t cells.", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:DUooU5lO8OsC", "citedby": "0"}, {"bib": {"title": "Differential Expression of Nicotinamide N-methyltransferase (NNMT) in Stroma of Invasive Breast Cancer", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:umqufdRvDiIC", "citedby": "0"}, {"bib": {"title": "Proteomics identifies CT45 as a mediator of chemosensitivity and immunotherapy target in ovarian cancer.", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ODE9OILHJdcC", "citedby": "0"}, {"bib": {"title": "Fatty acid binding protein 4 is indispensable for ovarian cancer metastasis.", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:yFnVuubrUp4C", "citedby": "0"}, {"bib": {"title": "Beta-escin inhibits ovarian cancer metastasis by targeting the tumor microenvironment.", "year": "2018"}, "source": "citations", "id_citations": "-57kTacAAAAJ:DJbcl8HfkQkC", "citedby": "0"}, {"bib": {"title": "Compartment-resolved proteomics reveal NNMT as a master metabolic regulator of cancer associated fibroblasts", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:YohjEiUPhakC", "citedby": "0"}, {"bib": {"title": "Abstract TMEM-118: ROLES OF T-LAK CELL-ORIGINATED KINASE (TOPK) AND THE MICROENVIRONMENT IN DRIVING OVARIAN CANCER PROGRESSION", "year": "2017"}, "source": "citations", "id_citations": "-57kTacAAAAJ:5qfkUJPXOUwC", "citedby": "0"}, {"bib": {"title": "Abstract B39: Identification and targeting mediators of chemoresistance using the patient-derived xenograft model of ovarian cancer", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:kz9GbA2Ns4gC", "citedby": "0"}, {"bib": {"title": "Ovarian cancer patients treated with intraperitoneal/intravenous chemotherapy do not experience increased toxicity at recurrence", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:kuK5TVdYjLIC", "citedby": "0"}, {"bib": {"title": "Abstract A68: Sphingosine kinase 1 as a mediator and predictor of metformin's protective effect in ovarian cancer.", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:p__nRnzSRKYC", "citedby": "0"}, {"bib": {"title": "Predictors of Early Recurrence in Advanced Stage, Optimally Debulked Ovarian Cancers", "year": "2016"}, "source": "citations", "id_citations": "-57kTacAAAAJ:oNZyr7d5Mn4C", "citedby": "0"}, {"bib": {"title": "Subsequent chemotherapy is well tolerated in patients who underwent primary adjuvant intraperitoneal chemotherapy for ovarian, fallopian and primary peritoneal cancers", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:vDijr-p_gm4C", "citedby": "0"}, {"bib": {"title": "A prospective study to evaluate diffusion weighted MRI imaging in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:epqYDVWIO7EC", "citedby": "0"}, {"bib": {"title": "Metformin acts to disrupt mitochondrial-associated metabolic homeostasis in human cancer", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:IRz6iEL74y4C", "citedby": "0"}, {"bib": {"title": "Lovastatin decreases macrophage IL-6 and CXCL1 production in an ovarian tam-like model reducing ovarian cancer cell invasion", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:AvfA0Oy_GE0C", "citedby": "0"}, {"bib": {"title": "Advancing metformin as therapeutic for ovarian cancer: metabolomic profiling of mouse ovarian tumors identifies metformin-induced global metabolic changes", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:uWiczbcajpAC", "citedby": "0"}, {"bib": {"title": "Abstract POSTER-BIOL-1305: Lovastatin decreases macrophage IL-6 and CXCL1 production in an ovarian tam-like model reducing ovarian cancer cell invasion", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:zLWjf1WUPmwC", "citedby": "0"}, {"bib": {"title": "Abstract POSTER-TECH-1123: Advancing metformin as therapeutic for ovarian cancer: metabolomic profiling of mouse ovarian tumors identifies metformin-induced global metabolic \u2026", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:EkHepimYqZsC", "citedby": "0"}, {"bib": {"title": "Abstract POSTER-CTRL-1217: Human placental lactogen-functionalized bimodal imaging probe for human ovarian cancer detection", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ipzZ9siozwsC", "citedby": "0"}, {"bib": {"title": "Abstract POSTER-THER-1440: Targeted delivery of doxorubicin loaded nanobins to ovarian cancer cells through the urokinase plasminogen activator system", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:uc_IGeMz5qoC", "citedby": "0"}, {"bib": {"title": "Abstract AS23: Microenvironment mediated downregulation of miR-193b promotes ovarian cancer metastasis", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:0KyAp5RtaNEC", "citedby": "0"}, {"bib": {"title": "Reversal of chemoresistance in ovarian cancer cells by the liposomal co-delivery of MDR inhibitors and paclitaxel", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:BwyfMAYsbu0C", "citedby": "0"}, {"bib": {"title": "Reversal of Chemoresistance in Ovarian Cancer by Co-Delivery of MDR Inhibitors and Paclitaxel Using a Targeted Liposomal Platform", "year": "2015"}, "source": "citations", "id_citations": "-57kTacAAAAJ:j8SEvjWlNXcC", "citedby": "0"}, {"bib": {"title": "Compositions and Methods for Treating and/or Preventing Cancer by Inhibiting Fatty Acid Binding Proteins", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:2VqYfGB8ITEC", "citedby": "0"}, {"bib": {"title": "Methods for treating ovarian cancer by inhibiting fatty acid binding proteins", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:uWQEDVKXjbEC", "citedby": "0"}, {"bib": {"title": "MicroRNA 206 is associated with longer overall survival and platinum sensitivity in serous epithelial ovarian cancer", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:tKAzc9rXhukC", "citedby": "0"}, {"bib": {"title": "THE ROLE OF THE GLUCOCORTICOID RECEPTOR (GR) IN INHIBITING CHEMOTHERAPY-INDUCED APOPTOSIS IN HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGS-OvCa).: PII-046", "year": "2014"}, "source": "citations", "id_citations": "-57kTacAAAAJ:WA5NYHcadZ8C", "citedby": "0"}, {"bib": {"title": "Ovarian cancer cells activate the mesothelium in the peritoneal microenvironment promoting fibronectin production and the early steps of metastasis", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:F9fV5C73w3QC", "citedby": "0"}, {"bib": {"title": "Abstract PR11: Ovarian cancer cells activate the mesothelium in the peritoneal microenvironment promoting fibronectin production and the early steps of metastasis", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:PELIpwtuRlgC", "citedby": "0"}, {"bib": {"title": "Abstract B32: The role of the glucocorticoid receptor (GR) in inhibiting chemotherapy-induced apoptosis in high-grade serous ovarian carcinoma (HGS-OvCa)", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:tkaPQYYpVKoC", "citedby": "0"}, {"bib": {"title": "Regulation of ovarian cancer metastatic colonization by MIR-193B", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:XiVPGOgt02cC", "citedby": "0"}, {"bib": {"title": "Identifying the microrna expression signature associated with chemoresistance in ovarian cancer", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:bnK-pcrLprsC", "citedby": "0"}, {"bib": {"title": "A prospective study to evaluate diffusion weighted MRI (DW-MRI) imaging in the detection of peritoneal carcinomatosis", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:kRWSkSYxWN8C", "citedby": "0"}, {"bib": {"title": "Tying Square Knots", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:0izLItjtcgwC", "citedby": "0"}, {"bib": {"title": "The developmental patterning gene HOXA9 promotes ovarian cancer growth via paracrine effects on mesenchymal stem cells and peritoneal fibroblasts.", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:HE397vMXCloC", "citedby": "0"}, {"bib": {"title": "Omental adipocytes promote overexpression of CD36 in ovarian cancer cells and enhance tumorigenicity.", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:t6usbXjVLHcC", "citedby": "0"}, {"bib": {"title": "Abstract IA30: Metabolic symbiosis: The contribution of adipocytes to visceral metastasis", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Mojj43d5GZwC", "citedby": "0"}, {"bib": {"title": "miR-92a Inhibits Peritoneal DisseminatmiR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin \u03b15 Expression", "year": "2013"}, "source": "citations", "id_citations": "-57kTacAAAAJ:N5tVd3kTz84C", "citedby": "0"}, {"bib": {"title": "CD95 promotes tumour growth (vol 465, pg 492, 2010)", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:a3BOlSfXSfwC", "citedby": "0"}, {"bib": {"title": "Corrigendum: CD95 promotes tumour growth", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Ehil0879vHcC", "citedby": "0"}, {"bib": {"title": "Urokinase plasminogen activator system targeted delivery of arsenic trioxide loaded nanobins as a novel ovarian cancer therapeutic", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:7T2F9Uy0os0C", "citedby": "0"}, {"bib": {"title": "Ovarian cancer cells induce fibronectin production in the peritoneal microenvironment through a TGF\u03b2RI-dependent mechanism which promotes the early steps of metastasis", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:NJ774b8OgUMC", "citedby": "0"}, {"bib": {"title": "Activation of c-Met receptor signaling by carcinoma-associated fibroblasts in the tumor microenvironment", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:W5xh706n7nkC", "citedby": "0"}, {"bib": {"title": "Utility of routine surveillance methods in detecting recurrence in high grade endometrial cancer patients", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:1sJd4Hv_s6UC", "citedby": "0"}, {"bib": {"title": "Metformin: A novel agent for ovarian cancer prevention and adjuvant treatment", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:NhqRSupF_l8C", "citedby": "0"}, {"bib": {"title": "Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity EDITORIAL COMMENT", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:nZcligLrVowC", "citedby": "0"}, {"bib": {"title": "The Stem Cell Associated Transcription Factor Sox2 as a Diagnostic Marker of Cervical Neoplasia", "year": "2012"}, "source": "citations", "id_citations": "-57kTacAAAAJ:B3FOqHPlNUQC", "citedby": "0"}, {"bib": {"title": "Locoregional Failure In High-risk Endometrial Cancer And The Role Of Whole Pelvis External Beam RT", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:08ZZubdj9fEC", "citedby": "0"}, {"bib": {"title": "Erratum: CD95 promotes tumour growth (Nature (2011) 471 (254", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:8xutWZnSdmoC", "citedby": "0"}, {"bib": {"title": "CD95 promotes tumour growth", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:L1USKYWJimsC", "citedby": "0"}, {"bib": {"title": "Identification of microRNA which regulates peritoneal dissemination of ovarian cancer", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:uLbwQdceFCQC", "citedby": "0"}, {"bib": {"title": "Modulation of lipid metabolism in interacting visceral adipocytes and ovarian cancer cells", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:eJXPG6dFmWUC", "citedby": "0"}, {"bib": {"title": "Erratum: CD95 promotes tumour growth", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:XUvXOeBm_78C", "citedby": "0"}, {"bib": {"title": "Sertoli-Leydig Cell Tumors: Just Variants of Granulosa Cell Tumors?-FOXL2, SOX9 and SAY Distinguish the Lineage of the Sex Cord Derivatives.", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:VOx2b1Wkg3QC", "citedby": "0"}, {"bib": {"title": "A role for adipocyte fatty acid binding protein in ovarian cancer progression", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:sSrBHYA8nusC", "citedby": "0"}, {"bib": {"title": "The Sertoli Cell Associated Molecule Doublesex and Mab-3 Related Transcription Factor 1 (DMRT-1) Is Not Expressed in Sertoli-Leydig Cell Tumors of the Ovary.", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:K3LRdlH-MEoC", "citedby": "0"}, {"bib": {"title": "The effects of 17\u03b2-estradiol and a selective estrogen receptor modulator, bazedoxifene, on ovarian carcinogenesis", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:LhH-TYMQEocC", "citedby": "0"}, {"bib": {"title": "Metformin Inhibits Growth and Invasion of Ovarian cancer; An Effect That Maybe Mediated By AMP-Activated Kinase", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:_5tno0g5mFcC", "citedby": "0"}, {"bib": {"title": "Physiologie und Pathologie des Geburtsbeginns", "year": "2011"}, "source": "citations", "id_citations": "-57kTacAAAAJ:u_35RYKgDlwC", "citedby": "0"}, {"bib": {"title": "Abstract A103: The effect of 17\u03b2-estradiol on ovarian carcinogenesis in vitro and in a genetic mouse model", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:UHK10RUVsp4C", "citedby": "0"}, {"bib": {"title": "Abstract LB-341: CD95/FAS promotes tumorigenesis", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:kzcrU_BdoSEC", "citedby": "0"}, {"bib": {"title": "One of the first steps of metastasis is remodeling of the extracellular matrix microenvironment", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:_Ybze24A_UAC", "citedby": "0"}, {"bib": {"title": "RUNX3 targets estrogen receptor a for proteasome-mediated degradation suppressing breast cancer tumorigenesis", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:uDGL6kOW6j0C", "citedby": "0"}, {"bib": {"title": "A clinicopathologic and immunohistochemical analysis of high-grade endometrial cancers associated with tamoxifen therapy", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:BrmTIyaxlBUC", "citedby": "0"}, {"bib": {"title": "Comparison of protein expression profiles of matched primary and metastatic papillary serous ovarian cancers using a reverse-phase protein array technology", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:5Ul4iDaHHb8C", "citedby": "0"}, {"bib": {"title": "Serial sectioning of the fallopian tube allows for improved identification of primary fallopian tube carcinoma", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:vRqMK49ujn8C", "citedby": "0"}, {"bib": {"title": "Metformin Inhibits Growth and Invasion in Several Ovarian Cancer Cell Lines; an Effect That May Be Mediated by Activation of AMP-Activated Kinase", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:WbkHhVStYXYC", "citedby": "0"}, {"bib": {"title": "FOXL2 And SOX9 Distinguish The Lineage Of The Sex Cord-Stromal Cells In Gonadoblastomas", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:PVjk1bu6vJQC", "citedby": "0"}, {"bib": {"title": "Expression of the VEGF/VEGFR2 Regulated Fatty Acid Binding Protein 4 (FABP4) in Endothelial Cells of Ovarian Carcinomas and Metastasis", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:fQNAKQ3IYiAC", "citedby": "0"}, {"bib": {"title": "Diagnostic Markers in the Differentiation of Gynecologic and Urological Clear Cell Carcinoma", "year": "2010"}, "source": "citations", "id_citations": "-57kTacAAAAJ:l7t_Zn2s7bgC", "citedby": "0"}, {"bib": {"title": "Abstract# 3888:\\# 945; 5-integrin regulates ovarian cancer metastasis through a c-Met/FAK/Src pathway", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:35r97b3x0nAC", "citedby": "0"}, {"bib": {"title": "Abstract# LB-16: The role of c-Met signaling in the tumor microenvironment of ovarian cancer", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:JQOojiI6XY0C", "citedby": "0"}, {"bib": {"title": "Hepatocyte growth factor and c-Met expression in uterine serous cancer", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:D_sINldO8mEC", "citedby": "0"}, {"bib": {"title": "Why does ovarian cancer metastasize to the omentum? A possible role for adipocytes in the promotion of ovarian cancer metastasis", "year": "2009"}, "source": "citations", "id_citations": "-57kTacAAAAJ:tS2w5q8j5-wC", "citedby": "0"}, {"bib": {"title": "519 POSTER A phase 2, single-arm study of volociximab (an anti-a5b1 integrin antibody) monotherapy in patients with platinum-resistant advanced epithelial ovarian cancer or \u2026", "year": "2008"}, "source": "citations", "id_citations": "-57kTacAAAAJ:O3NaXMp0MMsC", "citedby": "0"}, {"bib": {"title": "The evaluation of norethindrone, ethinyl estradiol and a GnRh agonist as chemoprevention of ovarian cancer using a newly developed genetically engineered mouse model of ovarian \u2026", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:VL0QpB8kHFEC", "citedby": "0"}, {"bib": {"title": "\u03923-Integrin expression reduces ovarian cancer proliferation and metastasis", "year": "2007"}, "source": "citations", "id_citations": "-57kTacAAAAJ:8AbLer7MMksC", "citedby": "0"}, {"bib": {"title": "P4. Tumor suppressor Pdcd4 inhibits invasion and regulates urokinase-receptor (u-PAR) gene expression via Sp-transcription factors", "year": "2006"}, "source": "citations", "id_citations": "-57kTacAAAAJ:pqnbT2bcN3wC", "citedby": "0"}, {"bib": {"title": "Development of an organotypic peritoneal 3D culture to study peritoneal attachment of ovarian cancer cells.", "year": "2006"}, "source": "citations", "id_citations": "-57kTacAAAAJ:g5m5HwL7SMYC", "citedby": "0"}, {"bib": {"title": "Down-regulation of the receptor tyrosine kinase c-Met inhibits invasion and adhesion of ovarian cancer cells", "year": "2006"}, "source": "citations", "id_citations": "-57kTacAAAAJ:70eg2SAEIzsC", "citedby": "0"}, {"bib": {"title": "Combination Analysis of Activator Protein-1Family Members, Sp1 and an Activator Protein-2A-Related Factor Binding to Different Regions of the Urokinase Receptor Gene in \u2026", "year": "2005"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ClCfbGk0d_YC", "citedby": "0"}, {"bib": {"title": "C-met expression in different types of ovarian epithelial tumors", "year": "2005"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4fKUyHm3Qg0C", "citedby": "0"}, {"bib": {"title": "Erste Hinweise auf eine Rolle des neu beschriebenen Tumor-Suppressorgens Pdcd4 als Regulator des Invasionsmolek\u00fcls Urokinase Rezeptor", "year": "2003"}, "source": "citations", "id_citations": "-57kTacAAAAJ:0CzhzZyukY4C", "citedby": "0"}, {"bib": {"title": "C-Met overexpression identifies breast cancer patients with poor clinical outcome independent of Her2/neu.", "year": "2003"}, "source": "citations", "id_citations": "-57kTacAAAAJ:eflP2zaiRacC", "citedby": "0"}, {"bib": {"title": "Erster Hinweis auf eine Rolle des neu beschriebenenen Tumor-Suppressorgens Pdcd4 als Regulator des Invasionsmolek\u00fcls Urokinase Rezeptor", "year": "2003"}, "source": "citations", "id_citations": "-57kTacAAAAJ:pyW8ca7W8N0C", "citedby": "0"}, {"bib": {"title": "Die Bedeutung intrazellul\u00e4rer Signalwege in gyn\u00e4kologischen Tumoren\u2014Von der Grundlagenforschung zur Therapie", "year": "2003"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ZHo1McVdvXMC", "citedby": "0"}, {"bib": {"title": "Molecular Oncology, Markers, Clinical Correlates-Tumor-specifle Transcription Factor Binding to an Activator Protein-2/Sp1 Element of the Urokinase-type Plasminogen Activator \u2026", "year": "2003"}, "source": "citations", "id_citations": "-57kTacAAAAJ:NaGl4SEjCO4C", "citedby": "0"}, {"bib": {"title": "Transcriptional Control of Proteases", "year": "2002"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4OULZ7Gr8RgC", "citedby": "0"}, {"bib": {"title": "First clinical evidence of a combined AP-2/Sp1 promoter motif as a tumor-specific activator of urokinase-receptor (u-PAR) expression in resected gastrointestinal cancers", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ns9cj8rnVeAC", "citedby": "0"}, {"bib": {"title": "CELL GROWTH AND DEVELOPMENT-b3A-Integrin Downregulates the Urokinase-Type Plasminogen Activator Receptor (u-PAR) through a PEA3/ets Transcriptional Silencing Element in the u \u2026", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:GFxP56DSvIMC", "citedby": "0"}, {"bib": {"title": "Regular Articles-Molecular Oncology, Markers, Clinical Correlates-Frequent Hypermethylation of the 5'CpG Island of E-Cadherin in Esophageal Adenocarcinoma.", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:PoWvk5oyLR8C", "citedby": "0"}, {"bib": {"title": "Regular Articles-Molecular Oncology-Increased Expression of Matrix Metalloproteinases (MMP)-2, MMP-9, and the Urokinase-Type Plasminogen Activator Is Associated with \u2026", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:_xSYboBqXhAC", "citedby": "0"}, {"bib": {"title": "MECHANISMS OF SIGNAL TRANSDUCTION-Integrin avb3/vitronectin interaction affects expression of the urokinase system in human ovarian cancer cells.", "year": "2001"}, "source": "citations", "id_citations": "-57kTacAAAAJ:f2IySw72cVMC", "citedby": "0"}, {"bib": {"title": "UVB-Strahlung induziert Plasminogenaktivator vom Urokinasetyp (uPA) und uPA-Rezeptor in der Keratinozytenlinie A431\u2014Bedeutung f\u00fcr die Photoprovozierbarkeit von Pemphigus vulgaris", "year": "2000"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Tiz5es2fbqcC", "citedby": "0"}, {"bib": {"title": "RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator Gene", "year": "2000"}, "source": "citations", "id_citations": "-57kTacAAAAJ:GnPB-g6toBAC", "citedby": "0"}, {"bib": {"title": "NUCLEIC ACIDS, PROTEIN SYNTHESIS, AND MOLECULAR GENETICS-Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor", "year": "1999"}, "source": "citations", "id_citations": "-57kTacAAAAJ:SeFeTyx0c_EC", "citedby": "0"}, {"bib": {"title": "Molecular cloning, expression and promoter analysis of the vesicular monoamine transporter subtype 2 (VMAT2) in human and rat gastric enterochromaffin-like (ECL) cells", "year": "1998"}, "source": "citations", "id_citations": "-57kTacAAAAJ:lSLTfruPkqcC", "citedby": "0"}, {"bib": {"title": "UVB induces the transcription of urokinase receptor in A431 cells", "year": "1998"}, "source": "citations", "id_citations": "-57kTacAAAAJ:bFI3QPDXJZMC", "citedby": "0"}, {"bib": {"title": "The clinical importance of keratin 18 in breast cancer", "year": "1995"}, "source": "citations", "id_citations": "-57kTacAAAAJ:u-coK7KVo8oC", "citedby": "0"}, {"bib": {"title": "Prognosekriterien des Mammakarzinoms am Beispiel der Keratine und des Onkogenproduktes HER2/neu", "year": "1993"}, "source": "citations", "id_citations": "-57kTacAAAAJ:a0OBvERweLwC", "citedby": "0"}, {"bib": {"title": "A Special Key for Unlocking the Door to Targeted Therapies of Breast Cancer", "year": "1970"}, "source": "citations", "id_citations": "-57kTacAAAAJ:rO6llkc54NcC", "citedby": "0"}, {"bib": {"title": "Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for t he study of the early steps of ovarian cancer metastasis."}, "source": "citations", "id_citations": "-57kTacAAAAJ:WHdLCjDvYFkC", "citedby": "0"}, {"bib": {"title": "Supplementary Methods for"}, "source": "citations", "id_citations": "-57kTacAAAAJ:7Hz3ACDFbsoC", "citedby": "0"}, {"bib": {"title": "Supplementary data to"}, "source": "citations", "id_citations": "-57kTacAAAAJ:Aul-kAQHnToC", "citedby": "0"}, {"bib": {"title": "CD95/Fas promotes tumour growth"}, "source": "citations", "id_citations": "-57kTacAAAAJ:ZzlSgRqYykMC", "citedby": "0"}, {"bib": {"title": "27th German Cancer Congress Berlin 2006"}, "source": "citations", "id_citations": "-57kTacAAAAJ:8d8msizDQcsC", "citedby": "0"}, {"bib": {"title": "27th German Cancer Congress Berlin 2006"}, "source": "citations", "id_citations": "-57kTacAAAAJ:4fGpz3EwCPoC", "citedby": "0"}, {"bib": {"title": "Elevated Keratin 18 Protein Expression Indicates a Favorable Prognosis in Patients with Breast Cancer\u2019"}, "source": "citations", "id_citations": "-57kTacAAAAJ:FPJr55Dyh1AC", "citedby": "0"}]}